“…We assessed gene expression in the hippocampus of mice 32 days following CSD, with and without post-defeat JB-1 and sertraline treatment; targeting genes related to stress response, social behavior and memory that had been previously identified as being modulated by JB-1 in other models 17 , 20 , 21 . For corticotropin-releasing hormone receptor subtypes (CRHR-1 and -2) and arginine vasopressin (AVPR-1a and -1b) in the hippocampus, we found that mice treated with JB-1 or sertraline had significantly lower expression of CRHR-1 mRNA relative to mice in defeat control group (F (2, 15) = 1.391, η 2 p = 0.16, defeat control: 0.81 ± 0.097, JB-1: 0.37 ± 0.049, g = 2.32, p = 0.0020; sertraline: 0.44 ± 0.061, g = 1.88, p = 0.0069) (Fig.…”